| Market Cap | $855.9M | |
| Enterprise Value | $832.3M | |
| Revenue | $6.5M | −81.3% |
| Gross Profit | $1.5M | −88.3% |
| EBITDA | -$12.4M | — |
| Net Income | -$45.0M | — |
| Diluted EPS | — | — |
| Free Cash Flow | — | — |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | 37.81% | 33.40% | 27.92% | 30.57% | 37.14% | 23.35% | 8% | 31% | |
| Operating Margin | −64.15% | −37.56% | −70.95% | −54.88% | −17.06% | −174.56% | 8% | 5% | |
| EBITDA Margin | −60.05% | −33.94% | −67.86% | −50.53% | −16.69% | −174.09% | 8% | 4% | |
| NOPAT Margin | −50.68% | −37.15% | −56.05% | −43.35% | −13.48% | — | — | — | |
| Net Margin | −139.32% | 7.36% | −71.93% | −59.00% | −0.48% | −688.80% | 8% | 4% | |
| FCF Margin | −17.98% | −26.54% | −37.96% | 0.20% | −12.57% | — | — | — | |
| OCF Margin | −17.62% | −25.77% | −37.60% | 0.25% | −12.46% | −124.63% | 8% | 4% | |
| Gross Profitability | 31.42% | 20.58% | 39.46% | 70.48% | 82.20% | 18.16% | 8% | 29% | |
| Capex Intensity | 0.35% | 0.77% | 0.36% | 0.05% | 0.12% | — | — | — | |
| ▸Returns on Capital · 6 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 3 ratios | |||||||||
| ▸Earnings quality · 5 ratios | |||||||||
| ▸Liquidity & coverage · 9 ratios | |||||||||
| ▸Leverage · 8 ratios | |||||||||
| ▸Working capital · 8 ratios | |||||||||
| ▸Capital allocation · 1 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|---|
| Revenue | $42.6M | $46.0M | $54.7M | $38.6M | $35.0M | $6.5M |
| YoY % | +8.0% | +18.8% | -29.4% | -9.4% | -81.3% | |
| Cost of Revenue | $26.5M | $30.6M | $39.4M | $26.8M | $22.0M | $5.0M |
| YoY % | +15.7% | +28.6% | -32.0% | -17.9% | -77.2% | |
| Gross Profit | $16.1M | $15.4M | $15.3M | $11.8M | $13.0M | $1.5M |
| YoY % | -4.6% | -0.7% | -22.7% | +10.1% | -88.3% | |
| R&D Expense | $100,000 | $500,000 | $500,000 | $100,000 | $100,000 | — |
| YoY % | +400.0% | 0.0% | -80.0% | 0.0% | ||
| Selling & Marketing Expense | $7.9M | — | — | — | — | — |
| SG&A Expense | $34.5M | $28.5M | $35.4M | $24.4M | $19.0M | $12.9M |
| YoY % | -17.3% | +24.3% | -31.0% | -22.5% | -31.8% | |
| Total Operating Expenses | $43.4M | $32.6M | $54.0M | $33.0M | $19.0M | $12.9M |
| YoY % | -24.8% | +65.5% | -39.0% | -42.5% | -31.8% | |
| Operating Income | -$27.3M | -$17.3M | -$38.8M | -$21.2M | -$6.0M | -$11.4M |
| Interest Expense | — | — | $551,000 | $1.4M | $467,000 | $628,000 |
| YoY % | +145.6% | -65.5% | +34.5% | |||
| Other Non-Operating Income | -$32.0M | $20.7M | -$551,000 | -$1.6M | $5.8M | $2.8M |
| YoY % | -52.4% | |||||
| Impairment of Real Estate | — | — | $8.5M | $8.5M | — | — |
| YoY % | 0.0% | |||||
| Pretax Income | -$59.3M | $3.4M | -$39.3M | -$22.8M | -$159,000 | -$8.6M |
| Income Tax | $0 | $37,000 | -$18,000 | $2,000 | $9,000 | — |
| YoY % | +350.0% | |||||
| Income from Discontinued Operations | — | — | — | — | -$43.1M | -$36.4M |
| Net Income (incl. NCI) | — | — | — | — | -$43.1M | -$8.6M |
| Net Income | -$59.3M | $3.4M | -$39.3M | -$22.8M | -$168,000 | -$45.0M |
| Net Income to Common | -$59.4M | $3.4M | -$39.3M | -$22.8M | -$168,000 | -$45.0M |
| EPS (Basic) | -$7.26 | $0.15 | -$58.93 | -$32.29 | -$0.10 | -$2.13 |
| EPS (Diluted) | -$7.26 | $0.14 | -$58.93 | -$32.29 | -$0.10 | -$2.13 |
| Weighted Avg Shares (Basic) | 8.2M | 19.9M | 667,114 | 705,185 | 1.6M | 21.1M |
| YoY % | +143.6% | -96.7% | +5.7% | +129.1% | +1206.5% | |
| Weighted Avg Shares (Diluted) | 8.2M | 21.9M | 667,114 | 705,185 | 1.6M | 21.1M |
| YoY % | +167.7% | -97.0% | +5.7% | +129.1% | +1206.5% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
